15 Mar 2008
People diagnosed with non-Hodgkin's lymphoma are living longer thanks to improvements in treatment, experts in the field have claimed.
Research carried out on nearly 86,000 patients from the US National Cancer Institute, suggests that targeted drugs coupled with chemotherapy have particularly helped the survival chances of younger people diagnosed with the disease.
A study published in the Archives of Internal Medicine shows that two-thirds of patients diagnosed between 2002 and 2004 will survive at least five years, Reuters reports.
This is a significant improvement on figures recorded between 1990 and 1992 which showed just half of patients surviving for the same period.
Furthermore, ten year survival rates also showed a noticeable improvement, projected to rise to 56 per cent in people first diagnosed with non-Hodgkin's lymphoma in the period 2002 to 2004.
This is up from 39 per cent in people diagnosed between 1990 and 1992.
"Improvements were most pronounced in patients younger than 45 years, but improvements were seen in all age groups," Dr Dianne Pulte from the German Cancer Research Centre in Heidelberg said.
Non-Hodgkin's lymphoma, a disease developing from cells of the lymphatic system, attacks the lymph nodes and spleen as well as other organs linked to the body's immune system.
According to figures in the European Journal of Cancer, incidences of non-Hodgkin's lymphoma rose by four per cent during the period 1985 to 1992.
Click here to learn more about non-Hodgkin's lymphoma
Delicious
Reddit
Facebook
StumbleUpon